GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » EV-to-EBIT

Cantourage Group SE (XTER:HIGH) EV-to-EBIT : 0.00 (As of Jun. 25, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cantourage Group SE's Enterprise Value is €0.00 Mil. Cantourage Group SE's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €0.06 Mil. Therefore, Cantourage Group SE's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Cantourage Group SE's EV-to-EBIT or its related term are showing as below:

XTER:HIGH' s EV-to-EBIT Range Over the Past 10 Years
Min: -116.59   Med: 0   Max: 0
Current: -20.58

XTER:HIGH's EV-to-EBIT is ranked worse than
100% of 669 companies
in the Drug Manufacturers industry
Industry Median: 16.85 vs XTER:HIGH: -20.58

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cantourage Group SE's Enterprise Value for the quarter that ended in Jun. 2023 was €0.00 Mil. Cantourage Group SE's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €0.06 Mil. Cantourage Group SE's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was %.


Cantourage Group SE EV-to-EBIT Historical Data

The historical data trend for Cantourage Group SE's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE EV-to-EBIT Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-EBIT
- - - -

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23
EV-to-EBIT Get a 7-Day Free Trial - - - - -

Competitive Comparison of Cantourage Group SE's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's EV-to-EBIT falls into.



Cantourage Group SE EV-to-EBIT Calculation

Cantourage Group SE's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/0.057
=0.00

Cantourage Group SE's current Enterprise Value is €0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cantourage Group SE's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE  (XTER:HIGH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cantourage Group SE's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=0.057/0
= %

Cantourage Group SE's Enterprise Value for the quarter that ended in Jun. 2023 was €0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cantourage Group SE's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE (XTER:HIGH) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE (XTER:HIGH) Headlines